fluoxetine has been researched along with Abortion, Tubal in 3 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Excerpt | Relevance | Reference |
---|---|---|
"Urinary SSRIs (fluoxetine, sertraline, escitalopram/citalopram) were measured while trying to conceive and, for women who became pregnant, at weeks 0, 4, and 8 of pregnancy." | 3.96 | Urinary selective serotonin reuptake inhibitors across critical windows of pregnancy establishment: a prospective cohort study of fecundability and pregnancy loss. ( Flannagan, KS; Kim, K; Mumford, SL; Perkins, NJ; Radoc, JG; Schisterman, EF; Silver, RM; Sjaarda, LA, 2020) |
"The rate of spontaneous pregnancy loss did not differ significantly between the women treated with fluoxetine and the control women (10." | 3.69 | Birth outcomes in pregnant women taking fluoxetine. ( Chambers, CD; Dick, LM; Felix, RJ; Johnson, KA; Jones, KL, 1996) |
"We evaluated outcomes of all pregnancies identified prospectively with confirmed first-trimester fluoxetine exposure contained in the Eli Lilly and Company worldwide fluoxetine pregnancy registry." | 3.69 | Effects of first-trimester fluoxetine exposure on the newborn. ( Corbin, LA; Goldstein, DJ; Sundell, KL, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Sjaarda, LA | 1 |
Radoc, JG | 1 |
Flannagan, KS | 1 |
Mumford, SL | 1 |
Kim, K | 1 |
Perkins, NJ | 1 |
Silver, RM | 1 |
Schisterman, EF | 1 |
Chambers, CD | 1 |
Johnson, KA | 1 |
Dick, LM | 1 |
Felix, RJ | 1 |
Jones, KL | 1 |
Goldstein, DJ | 1 |
Corbin, LA | 1 |
Sundell, KL | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Effects of Aspirin in Gestation and Reproduction: A Multi-center, Controlled, Double-blind Randomized Trial.[NCT00467363] | 1,228 participants (Actual) | Interventional | 2007-06-30 | Completed | |||
Transcranial Direct Current Stimulation (tDCS) for Depression in Pregnancy: A Pilot Study[NCT02116127] | 20 participants (Actual) | Interventional | 2014-04-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Partial or complete abruption (ie, premature separation of the placenta) (NCT00467363)
Timeframe: until delivery
Intervention | participants (Number) |
---|---|
Aspirin | 7 |
Placebo | 5 |
(NCT00467363)
Timeframe: 8-weeks
Intervention | pregnancy (Number) |
---|---|
Aspirin | 374 |
Placebo | 346 |
Implantation failures (NCT00467363)
Timeframe: 8 weeks
Intervention | pregnancy (Number) |
---|---|
Aspirin | 28 |
Placebo | 27 |
(NCT00467363)
Timeframe: within 6 weeks
Intervention | pregnancy (Number) |
---|---|
Aspirin | 3 |
Placebo | 3 |
(NCT00467363)
Timeframe: until 40 weeks
Intervention | pregnancy (Number) |
---|---|
Aspirin | 4 |
Placebo | 6 |
(NCT00467363)
Timeframe: within 8-weeks of gestation
Intervention | pregnancy (Number) |
---|---|
Aspirin | 394 |
Placebo | 363 |
Live birth was obtained prospectively by maternal report and abstraction from medical records by trained staff . (NCT00467363)
Timeframe: after delivery
Intervention | livebirths (Number) |
---|---|
Aspirin | 309 |
Placebo | 286 |
(NCT00467363)
Timeframe: 8 weeks
Intervention | pregnancy (Number) |
---|---|
Aspirin | 0 |
Placebo | 0 |
(NCT00467363)
Timeframe: until delivery
Intervention | participants (Number) |
---|---|
Aspirin | 32 |
Placebo | 30 |
Includes preembryonic and embryonic losses (exclusive of implantation failures) (NCT00467363)
Timeframe: less than 10-weeks
Intervention | pregnancy (Number) |
---|---|
Aspirin | 56 |
Placebo | 53 |
(NCT00467363)
Timeframe: until delivery
Intervention | infants (Number) |
---|---|
Aspirin | 22 |
Placebo | 31 |
birthweight (NCT00467363)
Timeframe: until delivery
Intervention | grams (Mean) |
---|---|
Aspirin | 3327 |
Placebo | 3315 |
(NCT00467363)
Timeframe: 40 weeks
Intervention | participants (Number) |
---|---|
Aspirin | 2 |
Placebo | 2 |
3 other studies available for fluoxetine and Abortion, Tubal
Article | Year |
---|---|
Urinary selective serotonin reuptake inhibitors across critical windows of pregnancy establishment: a prospective cohort study of fecundability and pregnancy loss.
Topics: Abortion, Spontaneous; Adult; Citalopram; Female; Fertility; Fluoxetine; Humans; Live Birth; Pregnan | 2020 |
Birth outcomes in pregnant women taking fluoxetine.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Affective Symptoms; Birth Weight; Case-Co | 1996 |
Effects of first-trimester fluoxetine exposure on the newborn.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adverse Drug Reaction Reporting Systems; Antidep | 1997 |